Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis (vol 12, pg 1457, 2023)

被引：0
|
作者：
Clavelou, Pierre [1 ,2 ]
Castelnovo, Giovanni [2 ]
Pourcher, Valerie [3 ]
De Seze, Jerome [4 ]
Vermersch, Patrick [5 ]
Ben-Amor, Ali-Frederic [6 ]
Savarin, Carine [7 ]
Defer, Gilles [8 ]
机构：
[1] Clermont Ferrand Univ Hosp, Dept Neurol, F-1 Clermont Ferrand, France
[2] Univ Nimes Hosp, Dept Neurol, Hop Caremeau, Nimes, France
[3] Inst Pierre Louis dEpidemiol & Sante Publ Paris, Sorbonne Univ, Pitie Salpetriere Hosp, Dept Infect & Trop Dis, Paris, France
[4] Strasbourg Univ Hosp, Dept Neurol, Strasbourg, France
[5] Univ Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France
[6] Global Med Affairs Neurol & Immunol, Ares Trading SA affiliate Merck KGaA, Darmstadt, Switzerland
[7] Dept Neurol, Med Affairs affiliate Merck KGaA, Darmstadt, France
[8] Caen Univ Hosp, Dept Neurol, Caen, France
来源：
NEUROLOGY AND THERAPY | 2024年 / 13卷 / 01期
关键词：
D O I：
10.1007/s40120-023-00564-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [1] Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
    Clavelou, Pierre
    Castelnovo, Giovanni
    Pourcher, Valerie
    De Seze, Jerome
    Vermersch, Patrick
    Ben-Amor, Ali-Frederic
    Savarin, Carine
    Defer, Gilles
    NEUROLOGY AND THERAPY, 2023, 12 (05) : 1457 - 1476
  • [2] Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
    Pierre Clavelou
    Giovanni Castelnovo
    Valérie Pourcher
    Jerome De Sèze
    Patrick Vermersch
    Ali-Frederic Ben-Amor
    Carine Savarin
    Gilles Defer
    Neurology and Therapy, 2023, 12 : 1457 - 1476
  • [3] Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
    Pierre Clavelou
    Giovanni Castelnovo
    Valérie Pourcher
    Jerome De Sèze
    Patrick Vermersch
    Ali-Frederic Ben-Amor
    Carine Savarin
    Gilles Defer
    Neurology and Therapy, 2024, 13 : 255 - 256
  • [4] Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates
    Jihad S. Inshasi
    Sarmed Alfahad
    Taoufik Alsaadi
    Ali Hassan
    Tayseer Zein
    Victoria Ann Mifsud
    Suzan Ibrahim Nouri
    Mustafa Shakra
    Ahmed Osman Shatila
    Miklos Szolics
    Mona Thakre
    Ajit Kumar
    Amir Boshra
    Neurology and Therapy, 2021, 10 : 435 - 454
  • [5] Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates
    Inshasi, Jihad S.
    Alfahad, Sarmed
    Alsaadi, Taoufik
    Hassan, Ali
    Zein, Tayseer
    Mifsud, Victoria Ann
    Nouri, Suzan Ibrahim
    Shakra, Mustafa
    Shatila, Ahmed Osman
    Szolics, Miklos
    Thakre, Mona
    Kumar, Ajit
    Boshra, Amir
    NEUROLOGY AND THERAPY, 2021, 10 (02) : 435 - 454
  • [6] Cladribine Tablets: In Relapsing-Remitting Multiple Sclerosis (vol 25, pg 239, 2011)
    Muir, Victoria J.
    Plosker, Greg L.
    CNS DRUGS, 2020, 34 (04) : 447 - 447
  • [7] Practical Guidance on the Use of Cladribine Tablets in the Management or Relapsing Multiple Sclerosis: Expert Opinion from Qatar
    Deleu, Dirk
    Canibano, Beatriz Garcia
    Elalamy, Osama
    Abdelmoneim, Mohamed Sayed
    Boshra, Amir
    DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2023, 13 : 81 - 88
  • [8] Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know
    Mohamed AlJumah
    Mona Marwan Alkhawajah
    Shireen Qureshi
    Ibtisam Al-Thubaiti
    Omar Ayoub
    Saeed A. Bohlega
    Areej Bushnag
    Edward Cupler
    Abdulkader Daif
    Ahmed El Boghdady
    Ahmed Hassan
    Yaser Al Malik
    Jameelah Saeedi
    Fawzia Al-Shamrany
    Eslam Shosha
    Peter Rieckmann
    Neurology and Therapy, 2020, 9 : 11 - 23
  • [9] Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
    Gavin Giovannoni
    Joela Mathews
    Neurology and Therapy, 2022, 11 : 571 - 595
  • [10] Expert Opinion on the Use of Cladribine Tablets in Clinical Practice for the Treatment of Relapsing Multiple Sclerosis
    Sorensen, Per Soelberg
    Centonze, Diego
    Giovannoni, Gavin
    Montalban, Xavier
    Selchen, Daniel
    Vermersch, Patrick
    Wiendl, Heinz
    Yamout, Bassem
    Salloukh, Hashem
    Rieckmann, Peter
    NEUROLOGY, 2020, 94 (15)
12345